Knockdown of CXCR4 Inhibits CXCL12-Induced Angiogenesis in HUVECs through Downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/β-Catenin Pathways

References

• Alonso-Camino V, Santos-Valle P, Ispizua MC, Sanz L, Alvarez-Vallina L. Engineered human tumor xenografts with functional human vascular networks. Microvasc Res. 2011;81:18–25. doi:10.1016/j.mvr.2010.10.002. PMID:20934439.
   PubMed Web of Science ®Google Scholar
• SunG Wei L, Feng J, Lin J, Peng J. Inhibitory effects of Hedyotis diffusa Willd. on colorectal cancer stem cells. Oncol Lett. 2016;11:3875–3881. PMID:27313710.
   PubMed Web of Science ®Google Scholar
• Elias AP, Dias S. Microenvironment changes (in pH) affect VEGF alternative splicing. Cancer Microenviron. 2008;1:131–139. doi:10.1007/s12307-008-0013-4. PMID:19308691.
   PubMedGoogle Scholar
• Aozuka Y, Koizumi K, Saitoh Y, Ueda Y, Sakurai H, Saiki I. Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice. Cancer Lett. 2004;216:35–42. doi:10.1016/j.canlet.2004.06.050. PMID:15500947.
   PubMed Web of Science ®Google Scholar
• Shibuta K, Mori M, Shimoda K, Inoue H, Mitra P, Barnard GF. Regional expression of CXCL12/CXCR4 in liver and colorectal cancer and cell-cycle variation during in vitro differentiation. Jpn J Cancer Res. 2002;93:789–797. doi:10.1111/j.1349-7006.2002.tb01321.x. PMID:12149145.
   PubMedGoogle Scholar
• Fleige H, Ravens S, Moschovakis GL, Bölter J, Willenzon S, Sutter G, et al. IL-17-induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs. J Exp Med. 2014;211:643–651. doi:10.1084/jem.20131737. PMID:24663215.
   PubMed Web of Science ®Google Scholar
• Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, et al. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence. J Clin Oncol. 2005;23:2744–2753. doi:10.1200/JCO.2005.07.078. PMID:15837989.
   PubMed Web of Science ®Google Scholar
• Salvucci O, Bouchard A, Baccarelli A, Deschênes J, Sauter G, Simon R, et al. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res Treat. 2006;97:275–283. doi:10.1007/s10549-005-9121-8. PMID:16344916.
   PubMed Web of Science ®Google Scholar
• Ghosh MC, Makena PS, Gorantla V, Sinclair SE, Waters CM. CXCR4 regulates migration of lung alveolar epithelial cells through activation of Rac1 and matrix metalloproteinase-2. Am J PhySiol Lung Cell Mol PhySiol. 2012;302:L846–L856. doi:10.1152/ajplung.00321.2011. PMID:22345572.
   PubMed Web of Science ®Google Scholar
• Pauls E, Ruiz A, Badia R, Permanyer M, Gubern A, Riveira-Muñoz E, et al. Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells. J Immunol. 2014;193:1988–1997. doi:10.4049/jimmunol.1400873. PMID:25015816.
   PubMed Web of Science ®Google Scholar
• Ratajczak MZ, Zuba-Surma E, Kucia M, Reca R, Wojakowski W, Ratajczak J. The pleiotropic effects of the SDF-1–CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia. 2006;20:1915–1924. doi:10.1038/sj.leu.2404357. PMID:16900209.
   PubMed Web of Science ®Google Scholar
• Chao C, Carmical JR, Ives KL, Wood TG, Aronson JF, Gomez GA, et al. CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133− cells. Lab Invest. 2012;92:420–436. doi:10.1038/labinvest.2011.185. PMID:22157717.
   PubMed Web of Science ®Google Scholar
• Saigusa S, Toiyama Y, Tanaka K, Yokoe T, Okugawa Y, Fujikawa H, et al. Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy. Int J Oncol. 2011;38:655–663. doi:10.3892/ijo.2011.906. PMID:21240461.
   PubMed Web of Science ®Google Scholar
• Shi MD, Chen JH, Sung HT, Lee JS, Tsai LY, Lin HH. CXCL12-G801A polymorphism modulates risk of colorectal cancer in Taiwan. Arch Med Sci. 2013;9:999–1005. doi:10.5114/aoms.2013.39211. PMID:24482642.
   PubMed Web of Science ®Google Scholar
• Ottaiano A, Franco R, Aiello Talamanca A, Liguori G, Tatangelo F, Delrio P, et al. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor prots predicts early distant relapse in stage II-III colorectal cancer patients. Clin Cancer Res. 2006;12:2795–2803. doi:10.1158/1078-0432.CCR-05-2142. PMID:16675573.
   PubMed Web of Science ®Google Scholar
• Schimanski CC, Galle PR, Moehler M. Chemokine receptor CXCR4-prognostic factor for gastrointestinal tumors. World J Gastroenterol. 2008;14:4721–4724. doi:10.3748/wjg.14.4721. PMID:18720530.
   PubMed Web of Science ®Google Scholar
• Ray P, Stacer AC, Fenner J, Cavnar SP, Meguiar K, Brown M, et al. CXCL12-γ in primary tumors drives breast cancer metastasis. Oncogene. 2015;34:2043–2051. doi:10.1038/onc.2014.157. PMID:24909174.
   PubMed Web of Science ®Google Scholar
• Kasagi Y, Harada Y, Morodomi Y, Iwai T, Saito S, Yoshida K, et al. Peritoneal dissemination requires an Sp1-dependent CXCR4/CXCL12 signaling axis and extracellular matrix-directed spheroid formation. Cancer Res. 2016;76:347–357. doi:10.1158/0008-5472.CAN-15-1563. PMID:26744523.
   PubMed Web of Science ®Google Scholar
• Wang L, Li CL, Wang L, Yu WB, Yin HP, Zhang GY, et al. Influence of CXCR4/SDF-1 axis on E-cadherin/β-catenin complex expression in HT29 colon cancer cells. World J Gastroenterol. 2011;17:625–632. doi:10.3748/wjg.v17.i5.625. PMID:21350711.
   PubMed Web of Science ®Google Scholar
• Yue B, Zhang YS, Xu HM, Zhao CR, Li YY, Qin YZ, et al. Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human hepatocellular carcinoma growth through induction of apoptosis in p53-dependent way. Cancer Lett. 2013;328:104–113. doi:10.1016/j.canlet.2012.09.002. PMID:22995069.
   PubMed Web of Science ®Google Scholar
• Dua P, Gude RP. Pentoxifylline impedes migration in B16F10 melanoma by modulating Rho GTPase activity and actin organisation. Eur J Cancer. 2008;44:1587–1595. doi:10.1016/j.ejca.2008.04.009. PMID:18495474.
   PubMed Web of Science ®Google Scholar
• Subarsky P, Hill RP. Graded hypoxia modulates the invasiv potential of HT1080 fibrosarcoma and MDA MB231 carcinoma cells. Clin Exp Metastasis. 2008;25:253–264. doi:10.1007/s10585-007-9139-x. PMID:18188670.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917. doi:10.1002/ijc.25516.
   PubMed Web of Science ®Google Scholar
• Song ZY, Gao ZH, Chu JH, Han XZ, Qu XJ. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells. Biomed Pharmacother. 2015;71:46–52. doi:10.1016/j.biopha.2015.01.020. PMID:25960214.
   PubMed Web of Science ®Google Scholar
• Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141:52–67. doi:10.1016/j.cell.2010.03.015. PMID:20371345.
   PubMed Web of Science ®Google Scholar
• Lindsey ML, Iyer RP, Zamilpa R, Yabluchanskiy A, DeLeon-Pennell KY, Hall ME, et al. A novel collagen matricryptin reduces left ventricular dilation post-myocardial infarction by promoting scar formation and angiogenesis. J Am Coll Cardiol. 2015;66:1364–1374. doi:10.1016/j.jacc.2015.07.035. PMID:26383724.
   PubMed Web of Science ®Google Scholar
• Liu P, Begley M, Michowski W, Inuzuka H, Ginzberg M, Gao D, et al. Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus. Nature. 2014;508:541–545. doi:10.1038/nature13079. PMID:24670654.
   PubMed Web of Science ®Google Scholar
• Castel P, Ellis H, Bago R, Toska E, Razavi P, Carmona FJ, et al. PDK1-SGK1 signaling sustains AKT-independent mTORC1 activation and confers resistance to PI3Kα inhibition. Cancer Cell. 2016;30:229–242. doi:10.1016/j.ccell.2016.06.004. PMID:27451907.
   PubMed Web of Science ®Google Scholar
• Vora SR, Juric D, Kim N, Mino-Kenudson M, Huynh T, Costa C, et al. CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitors. Cancer Cell. 2014;26:136–149. doi:10.1016/j.ccr.2014.05.020. PMID:25002028.
   PubMed Web of Science ®Google Scholar
• Lu S, Jang H, Gu S, Zhang J, Nussinov R. Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view. Chem Soc Rev. 2016;45:4929–4952. doi:10.1039/C5CS00911A. PMID:27396271.
   PubMed Web of Science ®Google Scholar
• Li VS, Ng SS, Boersema PJ, Low TY, Karthaus WR, Gerlach JP, et al. Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex. Cell. 2012;149:1245–1256. doi:10.1016/j.cell.2012.05.002. PMID:22682247.
   PubMed Web of Science ®Google Scholar
• Jin T. Current understanding on role of the Wnt signaling pathway effector TCF7L2 in glucose homeostasis. Endocr Rev. 2016;37:254–277. doi:10.1210/er.2015-1146. PMID:27159876.
   PubMed Web of Science ®Google Scholar